Dr Reddy's launches Fexofenadine HCl in US

15 Apr 2011 Evaluate

In a bid to tap $452 million Fexofenadine drug market, Dr Reddy's Laboratories has launched the generic version of Allegra (Fexofenadine HCl) tablets in the US market. The pharmaceutical firm will market the over-the-counter (OTC) product under store brand labels in the US market.  The products are bio equivalent versions of Sanofi-Aventis' Allegra tablets which received Rx-to-OTC switch approval from the FDA on January 24.crackcrack

Dr. Reddys Lab Share Price

1276.55 -0.45 (-0.04%)
05-Dec-2025 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1805.00
Dr. Reddys Lab 1276.55
Cipla 1520.55
Zydus Lifesciences 933.10
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×